Days after announced trade truce, China’s government explains ‘social credit score’ consequences for IP infringers first floated three years ago. Penalties range from borrowing restrictions to air travel bans.
This year's event in Shanghai has now come to an end. It's been a great couple of days, including the IP Asia Elite Gala Dinner and Awards held last night
How Chinese courts will rule the patent world; Qualcomm's 5G licensing spree; don't jail trolls, says former supreme court judge; patent sales are on the up; plus a whole lot more from a wet, but spectacular, Shanghai Pudong
Read more
First application of the court’s SimpleAir standard led to a 45% slump in Invidior’s share price and could prove to be a boon for generics companies
Read more
Life sciences companies in the United States are under increasing pressure. Campaigners for changes to the patent system are working to prevent what they see as abusive practices – and it looks as if they are winning the argument.
Read more
Previous FRAND-related rulings indicate judges in China could set a global rate, would adopt the hard-edged non-discrimination obligation and would consider the parties' negotiation behaviours when reaching their decisions
Read more
TCL v Ericsson and Unwired Planet v Huawei send two very different messages to auto companies being approached by patent pools such as Avanci to take SEP licences, says Unified Patents' chief IP counsel Jonathan Stroud
Read more
Life sciences IP is on the front line as American consumers, legislators and the Trump administration kick back against the high cost of medicines. Reform campaigners say they have never been more confident of change.
Read more
The landmark judgment makes it harder for pharmaceutical companies to use what has become an important source of protection – so opening the way for more generic competition
Read more
Shanghai Xuanpu appears to have risen from ashes of a state-backed semiconductor venture. Recent validity decisions mean its activities should be monitored by anyone implementing the TD-SCDMA standard in China
Read more
In overturning a lower court decision to invalidate, the court has provided some welcome relief to those holding rights in the field - but for applicants there remains a great deal of uncertainty
Read more
A pair of recent decisions from the Federal Court of Australia suggest that it may be about to become more difficult for drug patent owners to prevail in requests for interlocutory injunctions.
Read more
The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative.
Read more
The UPC and EU trademarks will not inflame any Brexit passions among those outside the IP bubble, but geographical indications are a different matter altogether
Read more
No one expected the Supreme Court to turn the US patent system upside down with Oil States – and it did not. But its SAS judgment issued on the same day could mean some big post-grant changes. Meanwhile, Andrei Iancu is exhibiting pro-patent inclinations Read more
SEP owners had much to celebrate in 2017 but a major decision from a US court meant that the year ended with a familiar amount of uncertainty Read more
@IAM_magazine RT @innovatornet: Japan to extend copyright period on works including novels and paintings to 70 years on Dec. 30 | The Japan Times https:/…Read more
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.
